Granuloma formation (implied in the context of immune response): An organized collection of immune cells, primarily macrophages, that surround and contain the Mycobacterium tuberculosis infection within tissues, aiming to limit its spread.
Caseous necrosis (within granulomas): A distinctive form of tissue death characterized by a soft, cheese-like appearance, occurring inside granulomas as a result of the immune response to TB infection.
Pathogenesis of TB involving alveolar macrophages: The process by which Mycobacterium tuberculosis enters the body, travels to alveoli, and is ingested by alveolar macrophages, which are unable to destroy the bacteria, leading to an inflammatory response and granuloma formation.
Granuloma formation is the body's immune attempt to contain Mycobacterium tuberculosis, often featuring caseous necrosis within the granuloma, which reflects the ongoing battle between the pathogen and host defenses involving alveolar macrophages.
Reactivation | The process where a granuloma that was previously formed to contain Mycobacterium tuberculosis becomes active again, leading to renewed disease. It occurs when the immune system is compromised, allowing dormant bacteria to become active and spread.
Reinfection | The occurrence of new infection with Mycobacterium tuberculosis in an individual who is immunocompromised, resulting in the bacteria becoming active again and spreading, even if a prior granuloma was formed. It involves the bacteria becoming active again and spreading.
Reactivation involves dormant bacteria within granulomas becoming active again, often due to immune compromise, whereas reinfection refers to new bacterial infection leading to active disease in immunocompromised individuals.
Direct Spread: Transmission of TB infection through contact with infected pleura or pericardium, leading to localized infection in these areas.
Via Bronchi: Spread of TB from the lungs to the larynx or other bronchi, potentially causing TB bronchopneumonia and large areas of lung consolidation.
Through Pulmonary Veins: Dissemination of TB bacteria into the bloodstream via pulmonary veins, resulting in blood-borne infections such as TB meningitis, renal, and bone TB.
Blood-borne dissemination of TB: The process where TB bacteria enter the bloodstream and spread to various organs, causing systemic infections.
Lymphatic spread of TB: Movement of TB bacteria through lymphatic channels, leading to infection in lymph nodes and other tissues.
TB spreads through multiple routes—direct contact, airways, blood, and lymphatics—allowing it to infect localized areas or disseminate systemically, which influences clinical presentation and disease severity.
Tuberculosis typically presents with a chronic cough, hemoptysis, systemic symptoms, and characteristic radiological features like consolidation and cavitation, which are essential for diagnosis and disease assessment.
Mantoux skin test | A diagnostic tool involving intradermal injection of purified protein derivative (PPD) to detect delayed hypersensitivity reaction indicative of TB exposure. A positive test suggests prior exposure or infection.
ESR (Erythrocyte Sedimentation Rate) | A blood test measuring the rate at which red blood cells settle in a period of one hour. Elevated ESR indicates inflammation, which can be associated with active tuberculosis.
Chest X-ray for diagnosis | An imaging modality used to identify pulmonary involvement in TB, showing features such as consolidation, cavitation, or infiltrates, especially in the lung zones.
Use of antituberculosis drugs in treatment | Pharmacological therapy involving specific medications aimed at eradicating Mycobacterium tuberculosis, typically including multiple drugs over an extended period to prevent resistance and ensure cure.
Diagnosis of tuberculosis relies on a combination of immune testing (Mantoux), inflammatory markers (ESR), and imaging (chest X-ray), while effective treatment depends on the appropriate use of antituberculosis medications.
Permanent dilation of bronchi and bronchioles: A condition characterized by irreversible widening of the airways resulting from destruction of the muscular and elastic supporting tissue (source: "Bronchiectasis — Permanent dilation of Bronchi and Bronchioles").
Secondary bronchiectasis due to infection or obstruction: A form of bronchiectasis that develops as a consequence of persistent infection or blockage within the airways, leading to tissue destruction and dilation (source: "Secondary disease due to persistent infection or obstruction").
Patchy distribution: The pattern of bronchiectasis where affected areas are irregular and scattered throughout the lungs rather than being uniform or localized to a specific region.
Lower lobe predilection: The tendency for bronchiectasis to predominantly affect the lower lobes of the lungs, often due to gravity-dependent factors or regional susceptibility.
Bronchiectasis involves the irreversible dilation of bronchi and bronchioles caused by destruction of their muscular and elastic tissue.
It is often secondary to other conditions, especially those involving persistent infection or airway obstruction.
The distribution of bronchiectasis is typically patchy, with a preference for the lower lobes.
The morphological features include dilated bronchi that may appear cylindrical or saccular and are associated with inflammatory exudate, leading to epithelial desquamation and ulceration.
Bronchiectasis is a permanent, patchy dilation of the bronchi and bronchioles, predominantly affecting the lower lobes, often as a secondary consequence of infection or obstruction, resulting in structural airway damage.
Productive cough: A cough that expels mucus or phlegm from the respiratory tract, often seen in bronchiectasis due to mucus accumulation in dilated bronchi.
Episodic fever: Recurrent episodes of elevated body temperature, typically associated with infection or inflammation, common in bronchiectasis exacerbations.
Hemoptysis: Coughing up blood originating from the respiratory tract, frequently occurring in bronchiectasis due to damaged and inflamed bronchial vessels.
Management: postural drainage: A technique involving positioning the patient to facilitate drainage of mucus from the bronchi and bronchioles, aiding in clearance of secretions.
Management: antibiotics: Use of antimicrobial agents to treat or prevent bacterial infections in bronchiectasis, especially during exacerbations or persistent infections.
Bronchiectasis is characterized by permanent dilation of bronchi and bronchioles caused by destruction of muscles and elastic tissue, often secondary to persistent infection or obstruction.
Clinical features include a productive cough, episodic fever, and hemoptysis.
Morphologically, affected bronchi are dilated and distended, with a patchy distribution, predominantly in the lower lobes.
Inflammatory exudate within the walls causes epithelial desquamation and ulceration, contributing to symptoms and disease progression.
Treatment involves postural drainage to aid mucus clearance and antibiotics to control infection.
Bronchiectasis presents with productive cough, episodic fever, and hemoptysis, and is managed primarily through techniques like postural drainage and antibiotic therapy to reduce infection and improve airway clearance.
Lung cancer comprises various histological types with distinct characteristics, primarily spreading through hematogenous and lymphatic routes, with smoking and pollutants being key risk factors.
Lung disease caused by inhalation of mineral dust: A condition resulting from the inhalation of mineral particles such as coal, silica, asbestos, and beryllium, leading to lung tissue damage and fibrosis. (see section 10: Pneumoconiosis)
Impact of occupational exposure on lung health: The effect on lungs due to inhalation of harmful mineral dusts during work activities, which can cause diseases like pneumoconiosis, silicosis, and asbestosis, often leading to fibrosis, respiratory failure, or increased susceptibility to infections such as TB.
Role of inhaled particles in disease development: Inhaled mineral particles deposit in the respiratory tract, with particles over 5 μm reaching terminal airways and particles less than 1 μm depositing in alveoli. These particles induce inflammation, macrophage activation, and fibrosis, contributing to various lung diseases (e.g., silicosis, asbestosis).
Inhalation of mineral dusts during occupational activities plays a critical role in the development of environmental lung diseases, with particle size influencing deposition, tissue damage, and fibrosis, ultimately impairing lung function.
Pneumoconiosis: Lung disease caused by inhalation of mineral dust, mainly coal dust, silica, asbestos, and beryllium. Particles more than 5 um reach terminal airways and are cleared by alveolar macrophages, while particles less than 1 um deposit in alveoli, causing damage and fibrosis. (Source)
Asbestosis: A form of pneumoconiosis resulting from prolonged asbestos exposure, characterized by fibrosis starting in the lower lung zones, with clinical features of dyspnea and productive cough. X-ray shows calcific pleural plaques. (Source)
Silicosis: Lung disease caused by inhalation of silica dust, leading to damage of lung macrophages. Lesions are pale to blackened nodules in upper lung zones, progressing to fibrotic lesions and egg-shell calcification in hilar lymph nodes and pleura. (Source)
Particles less than 1 um: Deposit in alveoli, damage alveolar tissue, and promote fibrosis formation. (Source)
Pleural plaques: Calcific deposits on the pleura associated with asbestos exposure, indicating asbestos-related fibrosis. (Source)
Inhalation of mineral dust particles less than 1 um deposits in alveoli, causing alveolar damage and fibrosis, with asbestos exposure also leading to pleural plaques and fibrosis.
Silicosis: A lung disease caused by inhalation of silica particles, leading to nodular fibrosis predominantly in the upper zones of the lungs. It involves the formation of pale to blackened nodules and progresses to fibrotic lesions, with the potential to develop egg-shell calcification in hilar lymph nodes. Silicosis increases susceptibility to tuberculosis (TB).
Nodular fibrosis in upper lung zones: The formation of fibrous nodules mainly in the upper parts of the lungs due to silica particle deposition and the subsequent fibrotic response.
Egg-shell calcification: A characteristic radiological feature where calcification occurs in the rim of hilar lymph nodes, giving a shell-like appearance, often associated with silicosis.
Progression to fibrotic lesions: The evolution of initial nodular fibrosis into more extensive, dense fibrotic tissue, leading to stiffening and scarring of lung tissue.
Susceptibility to TB: Silicosis damages lung macrophages, impairing immune defenses, which makes the lungs more vulnerable to tuberculosis infection.
Clinical features: Symptoms include breathlessness and respiratory failure, often as the disease advances.
Silicosis involves nodular fibrosis primarily in the upper lung zones, with lesions that can become dense and fibrotic over time.
Egg-shell calcification is a hallmark radiological sign, indicating calcification around hilar lymph nodes.
The disease progresses from initial nodular formation to extensive fibrotic tissue, impairing lung function.
Silicosis increases the risk of tuberculosis due to damage to lung macrophages, which are crucial for immune defense.
Clinical presentation includes breathlessness and can lead to respiratory failure in advanced stages.
Silicosis is a progressive fibrotic lung disease characterized by nodular fibrosis in the upper zones, egg-shell calcification, and increased susceptibility to TB, with clinical features of breathlessness and potential respiratory failure.
Interstitium inflammation: The inflammatory response occurring within the lung interstitium, which involves the alveolar walls and supporting tissue, leading to tissue damage and potential fibrosis.
Fibrosis in parenchymal lung diseases: The formation of excess fibrous connective tissue within the lung parenchyma as a result of ongoing inflammation or injury, causing scarring, lung distortion, and impaired gas exchange.
Pathogenesis involving alveolitis, fibrosis, and lung distortion: The process begins with alveolitis—inflammation of alveolar spaces—spreading to the interstitium, resulting in fibrosis. The fibrotic tissue causes scarring and distortion of lung architecture, leading to compromised lung function.
(Absent in provided content; no section generated)
| Aspect | Tuberculosis Pathophysiology | Reinfection & Reactivation | Spread of Tuberculosis | Lung Cancer Types & Spread | Environmental Lung Diseases | Parenchymal Lung Diseases & Fibrosis |
|---|---|---|---|---|---|---|
| Key Process | Granuloma formation with caseous necrosis; immune response involving alveolar macrophages | Reactivation: dormant bacteria become active; Reinfection: new bacterial infection | Direct spread, via bronchi, pulmonary veins, lymphatics | Types: Small cell, non-small cell; spread via local invasion, lymphatics, blood | Inhalation of environmental agents (e.g., asbestos, silica) leading to lung damage | Fibrosis from chronic injury, inflammation, or exposure |
| Main Features | Organized immune cell collection, caseous necrosis | Reactivation: occurs in immunocompromised; Reinfection: new exposure | Localized or systemic; can cause disseminated disease | Small cell: aggressive; Non-small cell: includes adenocarcinoma, squamous cell | Asbestosis: pleural plaques, fibrosis; Silicosis: nodular fibrosis | Honeycombing, reticulations, progressive fibrosis |
| Author/Key Concept | "Granuloma formation" (implied immune response) | "Reactivation" and "Reinfection" (definitions) | "Blood-borne dissemination" (via pulmonary veins) | Know authors on "Lung cancer types" | Know "Asbestosis features" and "Silicosis effects" | Know "Fibrosis" features and causes |
Teste tes connaissances sur Lung Pathology and Disease Mechanisms avec 7 questions à choix multiples et corrections détaillées.
1. How does granuloma formation differ from caseous necrosis in the pathophysiology of tuberculosis?
2. What is a key characteristic feature of granulomas in tuberculosis?
Mémorisez les concepts clés de Lung Pathology and Disease Mechanisms avec 9 flashcards interactives.
Tuberculosis — immune response?
Granuloma formation with caseous necrosis
Granuloma formation — purpose?
Containment of Mycobacterium tuberculosis.
Reactivation vs Reinfection — difference?
Reactivation: dormant bacteria become active; Reinfection: new bacterial infection occurs
Importe ton cours et l'IA génère fiches, QCM et flashcards en 30 secondes.
Générateur de fiches